MOVING FORWARD

Invitational Conference on Drug User Activism

International Drug User Day
2003, October 31st/November 1st
Copenhagen, Denmark

The Danish Drug Users Union – BrugerForeningen and the Dutch National Interest Group of Drug Users – Landelijk Steunpunt Druggebruikers sponsor “Moving Forward” a meeting on drug user activism.

The gathering was to mark both the International Drug User Day and the 10th Anniversary of BrugerForeningen.

Announcement. PowerPoint Announcement describing the conference and International Drug User Day.

First Day

Program

Training Session

Personal Communication
Stan Ritzer – Nederland

Improving your personal appearence and communication skills.

Participants will receive personal one on one assistance on ways to improve their appearance. Discussion regarding the reasons that activists need to consider their appearance and personal presentation skills.

Workshops

Professionalising
Alan Joyce, Methadone Alliance
U.K.

(to be available)

Certified user advokates and experienced bystanders.

The process of professionalizing advocacy and training advocates. This workshop discusses the need to create a movement that is professional and the training necessary to develop professional advocates.

Networking
Tommy Larkin, USCE
Ireland

(to be available)

How to develop and sustain a network of allies?

Developing a network of supporters is important in affecting drug policy and systems advocacy. Maintaining the network requires organizing skills and leadership to create
a group of savy advocates and supporters.

Digital Age
Ossi Viljakakainen
Finland
Eliot Albert, Methadone Alliance
U.K.

Using Internet to find info related to drugs and drug users.

A workshop designed to demonstrate software and strategies to make the internet a powerful advocacy tool.

Smoozing in Denmark. A photo album of the conference.

Second Day

International Drug User Day

  • Early Afternoon Activities

    Socializing and lunch buffet at BF-house
    Visit to Memorial Site for Deceased Drug Users

    A tree was planted by willing hands of user activists from each nation gathered followed by a minute of silence.

  • Evening Activities

    Tour at Christiania
    Gala-dinner at restaurant Spiseloppen in Christiania

  • Social party at BrugerForeningen

Third Day

A day of rest.

Fourth Day

BrugerForeningen’s 10th Anniversary

Reports

Similar Posts

  • References

    Admin 09/12/2022

    Batki, S.L.  Treatment of intravenous drug users with AIDS:  The role of methadone maintenance.  Journal of Psychoactive Drugs 1988 20: 213-216. Legal Action Center. Beazer vs New York City Transit Authority: A Landmark Decision on Methadone Maintenance [Report].  New York: National Institute on Drug Abuse, 1975.   Des Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et…

  • FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction Drug

    Admin 03/17/2023

    FDA Talk Paper April 20, 2001 T01-15 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The FDA is strengthening warnings to physicians about serious cardiac adverse events associated with Orlaam (levomethadyl acetate HC), a drug for opiate addiction treatment. FDA has changed the Orlaam labeling to increase the strength of the warnings and to…

  • Click Page!

    Admin 04/11/2023

    How to use the Click Page The Click Page helps NAMA earn money. Clicking on a banner can earn from $.05 to $1 or more. All you have to do is go down the page and click on each banner. A window will open, wait a few seconds and then close it. You will find…

  • Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-2

    Admin 09/14/2022

     Responsible Medication Assisted Treatment (MAT) Advocacy First the ground rules! In every thing NAMA-R does the rights and dignity of the individual patient take precedence. It is never, ever, OK to violate that rule no matter how important the issue. NAMA-R has not and will never serve as an apologist for poor treatment. Everyone whether…

  • Publication Index

    Admin 02/09/2022

    Journal Articles Anderson, J. Methadone, history, pharmacology, outcomes, clinical issues and future trends. Advance 2002 April: 42-48. (PDF Format) Coates, E.A.; Brennan, D.; Logan, R.M.; Goss, A.N.; Scopacasa, B.; Spencer, A.J.; Gorkic, E. Hepatitis c and associated health problems. Australian Dental Journal 2000 45(2): 108-114. (PDF Format) D’Aunno, T.; Pollack, H.A. Changes in Methadone Treatment…